Exodus Point Capital Management, LP Theravance Biopharma, Inc. Transaction History
Exodus Point Capital Management, LP
- $16.4 Billion
- Q3 2024
A detailed history of Exodus Point Capital Management, LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 38,018 shares of TBPH stock, worth $374,857. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,018
Previous 80,955
53.04%
Holding current value
$374,857
Previous $686,000
55.39%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TBPH
# of Institutions
122Shares Held
47.3MCall Options Held
200Put Options Held
12.8K-
Madison Avenue Partners, LP New York, NY9.51MShares$93.8 Million9.44% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$73.5 Million1.94% of portfolio
-
Newtyn Management, LLC New York, NY4.5MShares$44.4 Million6.4% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$37.3 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$27.2 Million1.95% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $658M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...